🇺🇸 FDA
Patent

US 7850970

Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections

granted A61KA61K31/519A61K38/57

Quick answer

US patent 7850970 (Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections) held by The Regents of the University of Colorado expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/519, A61K38/57, A61K45/06, A61P